Cargando…

Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens

BACKGROUND: Abnormal uterine bleeding (AUB) lowers the quality of life of women. This study attempted to determine which treatment protocol of medroxyprogesterone acetate (MPA), 15 vs 10 day-administration in a luteal phase, provides better outcomes in women with ovulatory dysfunction-related AUB (A...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bender, Rukiye Ada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248354/ https://www.ncbi.nlm.nih.gov/pubmed/35746846 http://dx.doi.org/10.12659/MSM.936727

Ejemplares similares

Development and validation of a predictive model of abnormal uterine bleeding associated with ovulatory dysfunction: a case-control study
por: Zhang, Yue, et al.
Publicado: (2023)

Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma
por: Harmon, Quaker E., et al.
Publicado: (2022)

The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial
por: Soontrapa, Nisarath, et al.
Publicado: (2022)

Dissecting the mechanism of Yuzhi Zhixue granule on ovulatory dysfunctional uterine bleeding by network pharmacology and molecular docking
por: Li, Jialin, et al.
Publicado: (2020)

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial
por: Mir, Suhail Ahmad, et al.
Publicado: (2022)

Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections
por: Amanti, L, et al.
Publicado: (2011)

Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate
por: Yuasa-Shibasaki, Erina, et al.
Publicado: (2017)

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)

Successful treatment of Depot Medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in Adolescents
por: Rager, Kristin M., et al.
Publicado: (2006)

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem
por: Ozgoli, Giti, et al.
Publicado: (2015)

Effects of Long-term Use of Depo-medroxyprogesterone Acetate on Lipid Metabolism in Nepalese Women
por: Yadav, Binod Kumar, et al.
Publicado: (2011)

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive()
por: Schickler, Robyn, et al.
Publicado: (2020)

Abnormal uterine bleeding
por: Whitaker, Lucy, et al.
Publicado: (2016)

Abnormal Uterine Bleeding
por: Benetti-Pinto, Cristina Laguna, et al.
Publicado: (2017)

Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression
por: Morrison, Charles S., et al.
Publicado: (2020)

Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal Cancer*
por: Bloom, H. J. G.
Publicado: (1971)

Inhibitory Effects of Medroxyprogesterone Acetate on Mouse Endometrial Carcinogenesis
por: Niwa, Kenji, et al.
Publicado: (1995)

The use of a short course of Ulipristal Acetate for acute abnormal uterine bleeding in women without uterine fibroids
por: Lambrecht, I, et al.
Publicado: (2023)

An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract
por: Ayele, Hossaena, et al.
Publicado: (2021)

Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant
por: Deese, Jennifer, et al.
Publicado: (2021)

The Pathology of Abnormal Uterine Bleeding
por: Morse, Arthur H.
Publicado: (1933)

Abnormal Uterine Bleeding In Adolescents
por: Elmaoğulları, Selin, et al.
Publicado: (2018)

Biomarkers in abnormal uterine bleeding(†)
por: Chodankar, Rohan, et al.
Publicado: (2019)

Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
por: Russo, I. H., et al.
Publicado: (1989)

Incidence of Galactorrhea in Young Women Using Depot-Medroxyprogesterone Acetate
por: Omar, Hatim A., et al.
Publicado: (2006)

The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques
por: Daly, Michele B., et al.
Publicado: (2020)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022)

Dysfunctional Uterine Bleeding
por: Macgregor, T. N., et al.
Publicado: (1953)

Evaluation of platelet-rich plasma injection activity in the treatment of abnormal uterine bleeding
por: Turan, Gökçe, et al.
Publicado: (2018)

Diagnostic sign of intra uterine extra amniotic adhesions with 4D ultrasonography: Sheet on string
por: Çalışkan, Eray, et al.
Publicado: (2018)

Hemoglobin Levels and Platelet Counts after Hysteroscopy Due to Abnormal Uterine Bleeding
por: Jobda, Katarzyna, et al.
Publicado: (2022)

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
por: Lam, Clarissa, et al.
Publicado: (2016)

Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer
por: Yamamoto, Hitoshi, et al.
Publicado: (1991)

Approach to Abnormal Uterine Bleeding in Adolescents
por: Yaşa, Cenk, et al.
Publicado: (2020)

A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS
por: Awonuga, Awoniyi O., et al.
Publicado: (2023)

Hysteroscopy: A necessary method for detecting uterine pathologies in post-menopausal women with abnormal uterine bleeding or increased endometrial thickness
por: Sarvi, Fatemeh, et al.
Publicado: (2016)

Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
por: Becher, R., et al.
Publicado: (1989)

Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)

Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status
por: Meijer, Bartolomeus J., et al.
Publicado: (2018)

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)()()
por: Katz, Micah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mltfb6uoiu6t7ac4cm6jbq68j0